Evanson Asset Management LLC Boosts Position in UnitedHealth Group Incorporated (NYSE:UNH)

Evanson Asset Management LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 38.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,070 shares of the healthcare conglomerate’s stock after buying an additional 297 shares during the period. Evanson Asset Management LLC’s holdings in UnitedHealth Group were worth $550,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of UNH. Vanguard Group Inc. boosted its stake in shares of UnitedHealth Group by 1.4% during the first quarter. Vanguard Group Inc. now owns 80,630,913 shares of the healthcare conglomerate’s stock worth $41,119,347,000 after buying an additional 1,147,051 shares during the period. State Street Corp increased its holdings in shares of UnitedHealth Group by 1.6% in the first quarter. State Street Corp now owns 46,274,771 shares of the healthcare conglomerate’s stock valued at $23,598,745,000 after purchasing an additional 714,903 shares during the period. Capital World Investors grew its position in UnitedHealth Group by 2.8% in the 1st quarter. Capital World Investors now owns 34,805,861 shares of the healthcare conglomerate’s stock valued at $17,750,351,000 after buying an additional 935,552 shares during the last quarter. Capital International Investors lifted its stake in shares of UnitedHealth Group by 4.3% in the 4th quarter. Capital International Investors now owns 19,342,468 shares of the healthcare conglomerate’s stock worth $9,713,058,000 after acquiring an additional 790,219 shares during the period. Finally, Capital Research Global Investors raised its holdings in UnitedHealth Group by 8.3% during the first quarter. Capital Research Global Investors now owns 19,273,691 shares of the healthcare conglomerate’s stock worth $9,829,129,000 after purchasing an additional 1,482,338 shares in the last quarter. Institutional investors and hedge funds own 87.25% of the company’s stock.

Analyst Ratings Changes

UNH has been the subject of several recent analyst reports. Raymond James raised their price target on UnitedHealth Group from $620.00 to $635.00 in a report on Thursday. Loop Capital started coverage on shares of UnitedHealth Group in a report on Thursday, June 16th. They issued a “buy” rating and a $575.00 price target for the company. Mizuho upped their target price on shares of UnitedHealth Group from $550.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, August 10th. SVB Leerink upped their price target on UnitedHealth Group from $600.00 to $625.00 and gave the stock an “outperform” rating in a report on Monday, July 18th. Finally, UBS Group boosted their target price on UnitedHealth Group from $545.00 to $570.00 and gave the stock a “neutral” rating in a research report on Thursday, July 21st. Three equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $586.40.

UnitedHealth Group Price Performance

UNH opened at $517.46 on Friday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.77 and a current ratio of 0.77. The stock has a market capitalization of $484.02 billion, a PE ratio of 27.02, a P/E/G ratio of 1.61 and a beta of 0.76. UnitedHealth Group Incorporated has a 1 year low of $383.12 and a 1 year high of $553.29. The company’s 50 day simple moving average is $530.11 and its 200 day simple moving average is $512.45.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, topping the consensus estimate of $5.24 by $0.33. The business had revenue of $80.33 billion for the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The business’s quarterly revenue was up 12.6% on a year-over-year basis. During the same period last year, the company posted $4.70 EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 21.85 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th were paid a $1.65 dividend. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.28%. The ex-dividend date was Friday, September 9th. UnitedHealth Group’s dividend payout ratio is presently 34.46%.

Insider Activity at UnitedHealth Group

In other news, CEO Andrew Witty sold 11,376 shares of the stock in a transaction dated Monday, July 18th. The stock was sold at an average price of $527.90, for a total value of $6,005,390.40. Following the completion of the sale, the chief executive officer now owns 76,559 shares in the company, valued at $40,415,496.10. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other UnitedHealth Group news, Director Stephen J. Hemsley sold 99,312 shares of the firm’s stock in a transaction that occurred on Tuesday, July 26th. The stock was sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the completion of the sale, the director now owns 787,372 shares in the company, valued at approximately $420,669,238.44. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Andrew Witty sold 11,376 shares of the stock in a transaction that occurred on Monday, July 18th. The shares were sold at an average price of $527.90, for a total value of $6,005,390.40. Following the transaction, the chief executive officer now owns 76,559 shares of the company’s stock, valued at $40,415,496.10. The disclosure for this sale can be found here. In the last three months, insiders sold 139,051 shares of company stock worth $74,450,958. Corporate insiders own 0.40% of the company’s stock.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.